Childhood/AYA Cancer

Latest News

FDA
FDA Delivers Complete Response Letter to Remestemcel-L in Pediatric Steroid-Refractory aGVHD

August 7th 2023

The resubmitted biologics license application for remestemcel-L has been issued a complete response letter.

Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated Chemotherapy
Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated Chemotherapy

June 27th 2023

FDA
Blinatumomab Receives Full Approval for MRD-Positive B-Cell ALL

June 21st 2023

Neuroblastoma
Investigational CAR T Product GD2-CART01 Displays Safety and Efficacy in Pediatric Neuroblastoma

May 5th 2023

Medical card. Flat style © 4zevar -stockadobe.com
New Research Pinpoints Potential Risk Factors for Late Deaths in Childhood Cancer Survivors

March 25th 2023

Latest CME Events & Activities

2nd Annual International Congress on Pediatric Oncology

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

9th Annual School of Gastrointestinal Oncology® (SOGO®)

Register Now!

Clinical Vignettes: Inaugural International Congress on Pediatric Oncology

View More

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS

View More

BURST CME™: What Is the Real Risk in Lower-Risk MDS?

View More

BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?

View More

A Focus on Acute Myeloid Leukemia

View More

The Latest on Acute Lymphocytic Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Medical Crossfire®: Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

25th Annual International Lung Cancer Congress®

Register Now!

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

View More

Community Practice Connections™: Multidisciplinary Strategies for Improving Outcomes in CML from Frontline Care… and Beyond!

View More

7th Annual School of Nursing Oncology™

View More

Myeloma Management Considerations: Applying the Evidence With Monoclonal Antibody Based Regimens

View More

More News

© 2023 MJH Life Sciences

All rights reserved.